[HTML][HTML] Current and potential therapeutic options for infections caused by difficult-to-treat and pandrug resistant gram-negative bacteria in critically ill patients
H Giamarellou, I Karaiskos - Antibiotics, 2022 - mdpi.com
Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients
H Giamarellou, I Karaiskos - Antibiotics, 2022 - search.proquest.com
Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients.
H Giamarellou, I Karaiskos - Antibiotics (2079-6382), 2022 - search.ebscohost.com
Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
[HTML][HTML] Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients
H Giamarellou, I Karaiskos - Antibiotics, 2022 - ncbi.nlm.nih.gov
Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
Current and potential therapeutic options for infections caused by difficult-to-treat and pandrug resistant Gram-negative bacteria in critically ill patients.
H Giamarellou, I Karaiskos - 2022 - cabidigitallibrary.org
Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients
H Giamarellou, I Karaiskos - Antibiotics (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients.
H Giamarellou, I Karaiskos - Antibiotics (Basel, Switzerland), 2022 - europepmc.org
Carbapenem resistance in Gram-negative bacteria has come into sight as a serious global
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …
threat. Carbapenem-resistant Gram-negative pathogens and their main representatives …